Back to Agenda
[Special Lecture] Dynamic ASEAN Pharmaceutical Environment with Challenges and Opportunities
Session Chair(s)
Shun Jin, MBA
Head, Regulatory Affairs, APMA
Sandoz Asia Pacific Pharmaceutical Pte., Ltd., Singapore
In ASEAN, the regulatory environment is changing very fast. The dynamic regulatory requirement brings challenges to the industry. In 2017, the pharmaceutical law in Vietnam has been updated and implemented. Industry is trying to digest the new requirements in this regulation and the speaker form DAV will give the explanation on the key updates in the new regulation. In addition, there will be another presentation from industry perspective. The session explores the ASEAN pharmaceutical environment from the onset of the ASEAN Consultative Committee for Standards and Quality (ACCSQ) Pharmaceutical Product Working Group (PPWG), Technical Working Groups (TWG), Implementation Working Group (IWG) and ASEAN guidelines. Providing insights on the latest development in PPWG, updates and future area of guidance discussion. Discussing the challenges faced by industry members and opportunities for industry in creating favourable regulatory environment in expediting approval of innovative medicines for patients in ASEAN.
Speaker(s)
Regulatory Environment in Vietnam
Mai Huong Thi Nguyen
Drug Administration of Vietnam, Vietnam
Officer, Drug Registration Division
ASEAN Pharmaceutical Environment: Industry Perspective on Challenges, Opportunities and Prospects of Partnerships
Kum Cheun Wong, PharmD
Novartis Asia Pacific Pharmaceuticals Pte. Ltd., Singapore
Head Asia Pacific Regulatory & Development Policy
Have an account?